NASDAQ:ORIAU Orion Biotech Opportunities (ORIAU) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free ORIAU Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$9.00▼$9.0050-Day Range$9.80▼$10.0252-Week Range$9.61▼$10.85VolumeN/AAverage Volume1,550 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Orion Biotech Opportunities alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Orion Biotech OpportunitiesOrion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.Read More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report ORIAU Stock News HeadlinesFebruary 29, 2024 | seekingalpha.comOrion Office REIT: Office Woes Bite Hard As Leverage ExplodesFebruary 28, 2024 | seekingalpha.comOrion Office REIT: The Downturn ContinuesApril 24, 2024 | Stansberry Research (Ad)The "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. February 1, 2024 | bizjournals.comAlbany NewsDecember 26, 2023 | seekingalpha.comOrion: 3 Reasons There Could Be Material Downside In 2024September 12, 2023 | benzinga.comOrion Previews AI-Powered Portfolio Comparison Tool at Future ProofAugust 1, 2023 | finanznachrichten.deRTW Biotech Opportunities - Use of Prometheus Biosciences' sale proceedsJuly 31, 2023 | benzinga.comOrion Group Partners With Leading HVAC Service Provider, Owens CompaniesApril 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.June 28, 2023 | thestreet.comBiotech Sector May Be Playing the Villain, But One Stock Is Set to SoarMay 16, 2023 | investing.comOrion Biotech Opportunities Corp (ORIA)April 17, 2023 | uk.finance.yahoo.comOrion Biotech Opportunities Corp. (ORIAW)February 18, 2023 | morningstar.comOrion Biotech Opportunities Corp Units (1 Ord Share Class A & 1/5 War) ORIAU Stock QuoteJanuary 26, 2023 | wsj.comOrion Biotech Opportunities Corp.July 5, 2022 | apnews.comORION BIOTECHNOLOGY ADDS GPCR EXPERT TO ITS SCIENTIFIC ADVISORY BOARDMay 6, 2022 | finance.yahoo.comOrion enters into exclusive agreement with Jemincare for novel non-opioid drug candidate for the treatment of painMarch 31, 2022 | finance.yahoo.comCould The Orion Biotech Opportunities Corp. (NASDAQ:ORIA) Ownership Structure Tell Us Something Useful?January 16, 2022 | nasdaq.comOrion Biotech Opportunities Corp. Units (ORIAU)October 5, 2021 | insidermonkey.com2 Best SPACs to Buy Based on Jonathan Esfandi’s JNE Partners’ Latest PortfolioSee More Headlines Receive ORIAU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orion Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Shell Companies Sub-IndustryN/A Current SymbolNASDAQ:ORIAU CUSIPN/A CIK1847416 WebN/A PhoneN/AFaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Zuie-Chin Huang M.B.A. (Age 55)CEO & Director Mr. Mark Kayal (Age 36)CFO & Sec. Mr. Robert Kenneth Simonds (Age 47)Gen. Counsel, Assistant Sec., VP & Director Key CompetitorsOmniLit AcquisitionNASDAQ:OLITWPerception Capital Corp. IINASDAQ:PCCTWVahanna Tech Edge Acquisition INASDAQ:VHNAWabrdn National Municipal Income FundNYSE:VFLAGM GroupNASDAQ:AGMHView All Competitors ORIAU Stock Analysis - Frequently Asked Questions When did Orion Biotech Opportunities IPO? Orion Biotech Opportunities (ORIAU) raised $200 million in an initial public offering (IPO) on Thursday, May 13th 2021. The company issued 20,000,000 shares at a price of $10.00 per share. Cantor acted as the underwriter for the IPO. This page (NASDAQ:ORIAU) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orion Biotech Opportunities Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
